Cardiac rupture complicating acute myocardial infarction: the clinical features from an observational study and

Qun Lu1, Ping Liu2, Jian-Hua Huo2

  • 1Department of Cardiovascular Medicine, First Affiliated Hospital, School of Medicine of Xi'an Jiaotong University, No.277 Yanta West Road, Xi'an, Shaanxi, 710061, P.R. China. luqun00@163.com.

BMC Cardiovascular Disorders
|September 11, 2020
PubMed

Insights

Cardiac rupture (CR) remains a significant threat in ST-elevation myocardial infarction (STEMI). Reperfusion therapy post-myocardial infarction effectively prevents CR in experimental models, offering a potential clinical strategy.

Area of Science:

  • Cardiology
  • Experimental Medicine
  • Pathophysiology

Background:

  • Cardiac rupture (CR) is a severe complication of ST-elevation myocardial infarction (STEMI).
  • Recent decades have seen a decline in CR incidence, but current clinical features and the impact of reperfusion therapy remain unclear.
  • This study investigates CR in STEMI patients and evaluates reperfusion therapy's effect in a mouse model.

Purpose of the Study:

  • To elucidate the current clinical characteristics of cardiac rupture in STEMI patients.
  • To assess the efficacy of reperfusion therapy in preventing cardiac rupture following myocardial infarction.
  • To identify predictors of cardiac rupture in STEMI.

Main Methods:

  • A clinical retrospective analysis of 1456 STEMI patients admitted between December 2015 and December 2018.
  • An experimental study involving 83 male C57BL/6 mice with induced myocardial infarction (MI), divided into permanent MI and reperfusion groups (1h and 4h ischemia).
  • Monitoring of mice for mortality and autopsy to determine causes of death, alongside clinical data analysis using multivariate logistic regression.

Main Results:

  • Cardiac rupture occurred in 1.4% of STEMI patients, with high in-hospital mortality (39%).
  • Independent predictors for CR included older age, elevated peak CK-MB, and peak hs-CRP.
  • In mice, 43.6% of those with permanent MI died from CR, whereas reperfusion therapy significantly improved survival, preventing CR.

Conclusions:

  • Cardiac rupture remains a critical cause of in-hospital mortality in STEMI.
  • Elderly patients with larger infarcts and severe inflammation are more susceptible to CR.
  • Experimental evidence strongly suggests that reperfusion therapy post-MI is protective against cardiac rupture.
Abstract

Related Concept Videos